TScan Therapeutics Inc. (TCRX)
Market Open
12 Jun, 13:56
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 92
0
0%
$
62.3M Market Cap
- P/E Ratio
- Div Yield
25,066 Volume
-1.04 Eps
$ 0.92
Previous Close Investors:
Want to track TCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TScan Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 John H. Burbank III Passport Capital LLC | 2.78M | $16.16M | $2.59M | -$13.57M | -83.98% |
| KPS Kyle P. Smith NewEdge Wealth LLC | 91,463 | $141,767.65 | $84,145.96 | -$57,621.69 | -40.65% |
